Jump to content

Subthalamic nucleus

From Wikipedia, the free encyclopedia
(Redirected from Subthalamic nuclei)

Subthalamic nucleus
Coronal slices of human brain showing the basal ganglia (external globus pallidus (GPe) and internal globus pallidus (GPi)), subthalamic nucleus (STN) and substantia nigra (SN).
DA-loops in Parkinson's disease
Details
Part ofSubthalamus (physically); basal ganglia (functionally)
Identifiers
Latinnucleus subthalamicus
Acronym(s)STN
MeSHD020531
NeuroNames435
NeuroLex IDnlx_anat_1010002
TA98A14.1.08.702
TA25709
FMA62035
Anatomical terms of neuroanatomy

The subthalamic nucleus (STN) is a small lens-shaped nucleus in the brain where it is, from a functional point of view, part of the basal ganglia system. In terms of anatomy, it is the major part of the subthalamus. As suggested by its name, the subthalamic nucleus is located ventral to the thalamus. It is also dorsal to the substantia nigra and medial to the internal capsule. It was first described by Jules Bernard Luys in 1865,[1] and the term corpus Luysi or Luys' body is still sometimes used.

Anatomy

[edit]
Structural connectivity of the human subthalamic nucleus as visualized through diffusion-weighted MRI.

Structure

[edit]

The principal type of neuron found in the subthalamic nucleus has rather long, sparsely spiny dendrites.[2][3] In the more centrally located neurons, the dendritic arbors have a more ellipsoidal shape.[4] The dimensions of these arbors (1200 μm, 600 μm, and 300 μm) are similar across many species—including rat, cat, monkey and human—which is unusual. However, the number of neurons increases with brain size as well as the external dimensions of the nucleus. The principal neurons are glutamatergic, which give them a particular functional position in the basal ganglia system. In humans there are also a small number (about 7.5%) of GABAergic interneurons that participate in the local circuitry; however, the dendritic arbors of subthalamic neurons shy away from the border and primarily interact with one another.[5]

The structure of the subthalamic nucleus has not yet been fully explored and understood, but it is likely composed of several internal domains. The primate subthalamic nucleus is often divided in three internal anatomical-functional domains. However, this so-called tripartite model has been debated because it does not fully explain the complexity of the subthalamic nucleus in brain function.[6][7]

Afferent axons

[edit]

The subthalamic nucleus receives its main input from the external globus pallidus (GPe),[8] not so much through the ansa lenticularis as often said but by radiating 'comb' fibers crossing the medial pallidum first and the internal capsule (forming part of Edinger's comb system, see figure), as well as the ansa subthalamica.[9] These afferents are GABAergic, inhibiting neurons in the subthalamic nucleus. Excitatory, glutamatergic inputs come from the cerebral cortex (entire frontal cortex with a predominance for motor, premotor and oculomotor input to the posterolateral part of the nucleus), and from the pars parafascicularis of the central complex. The subthalamic nucleus also receives neuromodulatory inputs, notably dopaminergic axons from the substantia nigra pars compacta.[10] It also receives inputs from the pedunculopontine nucleus.

Efferent targets

[edit]

The axons of subthalamic nucleus neurons leave the nucleus dorsally. The efferent axons are glutamatergic (excitatory). Except for the connection to the striatum (17.3% in macaques), most of the subthalamic principal neurons are multitargets and directed to the other elements of the core of the basal ganglia.[11] Some send axons to the substantia nigra medially and to the medial and lateral nuclei of the pallidum laterally (3-target, 21.3%). Some are 2-target with the lateral pallidum and the substantia nigra (2.7%) or the lateral pallidum and the medial (48%). Less are single target for the lateral pallidum. In the pallidum, subthalamic terminals end in bands parallel to the pallidal border.[11][12] When all axons reaching this target are added, the main efference of the subthalamic nucleus is, in 82.7% of the cases, clearly the internal globus pallidus (GPi).

Some researchers have reported internal axon collaterals.[13] However, there is little functional evidence for this.

Physiology

[edit]
Anatomical overview of the main circuits of the basal ganglia. Subthalamic nucleus is shown in red. Picture shows 2 coronal slices that have been superimposed to include the involved basal ganglia structures. + and - signs at the point of the arrows indicate respectively whether the pathway is excitatory or inhibitory in effect. Green arrows refer to excitatory glutamatergic pathways, red arrows refer to inhibitory GABAergic pathways and turquoise arrows refer to dopaminergic pathways that are excitatory on the direct pathway and inhibitory on the indirect pathway.

Subthalamic nucleus

[edit]

The first intracellular electrical recordings of subthalamic neurons were performed using sharp electrodes in a rat slice preparation.[citation needed] In these recordings three key observations were made, all three of which have dominated subsequent reports of subthalamic firing properties. The first observation was that, in the absence of current injection or synaptic stimulation, the majority of cells were spontaneously firing. The second observation is that these cells are capable of transiently firing at very high frequencies. The third observation concerns non-linear behaviors when cells are transiently depolarized after being hyperpolarized below –65mV. They are then able to engage voltage-gated calcium and sodium currents to fire bursts of action potentials.

Several recent studies have focused on the autonomous pacemaking ability of subthalamic neurons. These cells are often referred to as "fast-spiking pacemakers",[14] since they can generate spontaneous action potentials at rates of 80 to 90 Hz in primates.

Oscillatory and synchronous activity[15][16] is likely to be a typical pattern of discharge in subthalamic neurons recorded from patients and animal models characterized by the loss of dopaminergic cells in the substantia nigra pars compacta, which is the principal pathology that underlies Parkinson's disease.

Lateropallido-subthalamic system

[edit]

Strong reciprocal connections link the subthalamic nucleus and the external segment of the globus pallidus. Both are fast-spiking pacemakers. Together, they are thought to constitute the "central pacemaker of the basal ganglia"[17] with synchronous bursts.

The connection of the lateral pallidum with the subthalamic nucleus is also the one in the basal ganglia system where the reduction between emitter/receiving elements is likely the strongest. In terms of volume, in humans, the lateral pallidum measures 808 mm3, the subthalamic nucleus only 158 mm3.[18] This translated in numbers of neurons represents a strong compression with loss of map precision.

Some axons from the lateral pallidum go to the striatum.[19] The activity of the medial pallidum is influenced by afferences from the lateral pallidum and from the subthalamic nucleus.[20] The same for the substantia nigra pars reticulata.[12] The subthalamic nucleus sends axons to another regulator: the pedunculo-pontine complex (id).

The lateropallido-subthalamic system is thought to play a key role in the generation of the patterns of activity seen in Parkinson's disease.[21]

Pathophysiology

[edit]

Lesioning the STN leads to alleviation of motor symptoms such as akinesia, rigidity, and tremor in Parkinson disease. This was first shown in the MPTP primate model in a paper by Bergman and colleagues.[22] This inspired Benazzouz and colleagues to probe deep brain stimulation of the nucleus, which was known to exert similar effects as ablative lesions.[23] Soon after, the team of Alim Louis Benabid showed that deep brain stimulation of the nucleus leads to symptom relief in human patients with Parkinson disease, as well,[24] which led to the establishment of the currently FDA approved and widely applied form of deep brain stimulation. The first to be stimulated are the terminal arborisations of afferent axons, which modify the activity of subthalamic neurons. However, it has been shown in thalamic slices from mice,[25] that the stimulus also causes nearby astrocytes to release adenosine triphosphate (ATP), a precursor to adenosine (through a catabolic process). In turn, adenosine A1 receptor activation depresses excitatory transmission in the thalamus, thus mimicking ablation of the subthalamic nucleus.

Before the Bergman paper, the stereotactic field avoided lesioning the nucleus, since it was known that unilateral destruction or disruption of the subthalamic nucleus — which may result from naturally occurring strokes — may lead to hemiballismus. While this remains generally true, iatrogenic lesioning of the STN has been carried out numerous times and has recently gained new wind with the advent of MR guided focused ultrasound, which has also been probed for subthalamic nucleotomies to treat Parkinson disease.[26] Curiously, a team around Michael Fox could recently show that, while some lesions that led to hemiballism were indeed in and around the STN, the majority of reported cases were in other regions of the brain.[27]

As one of the STN's suspected functions is in impulse control, dysfunction in this region has been implicated in obsessive–compulsive disorder.[28] Application of high frequency pulses by deep brain stimulation has shown some promise in correcting severe impulsive behavior and has been FDA approved for treatment resistant cases with the disorder.[29]

Function

[edit]

The function of the STN is unknown, but current theories place it as a component of the basal ganglia control system that may perform action selection. It is plays a part in the so-called "hyperdirect" and "indirect" pathways of motor control, contrasting with the direct pathway which is thought to bypass the STN on its way from Striatum to internal pallidum. STN dysfunction has been implicated in motor symptoms such as rigidity, bradykinesia and tremor,[30] behavioral features such as stopping of ongoing movements[31] or impulsivity in individuals presented with two equally rewarding stimuli.[32]

The physiological role of the STN has been for long hidden by its pathological role. But lately, the research on the physiology of the STN led to the discovery that the STN is required to achieve intended movement, including locomotion, balance and motor coordination. It is involved in stopping or interrupting on-going motor tasks. Moreover, STN excitation was generally correlated with significant reduction in locomotor activity, while in contrast, STN inhibition enhanced locomotion.[33][34][35]

Additional images

[edit]
  • Coronal section of brain immediately in front of pons. Subthalamic nucleus labeled as "Nucleus of Luys".
    Coronal section of brain immediately in front of pons. Subthalamic nucleus labeled as "Nucleus of Luys".

See also

[edit]
Wikimedia Commons has media related to Subthalamic nucleus.

References

[edit]
  1. ^ Luys JB (1865). Recherches sur le système cérébro-spinal, sa structure, ses fonctions et ses maladies (in French). Paris: Baillière.
  2. ^ Afsharpour S (June 1985). "Light microscopic analysis of Golgi-impregnated rat subthalamic neurons". The Journal of Comparative Neurology. 236 (1): 1–13. doi:10.1002/cne.902360102. PMID 4056088. S2CID 12482772.
  3. ^ Rafols JA, Fox CA (July 1976). "The neurons in the primate subthalamic nucleus: a Golgi and electron microscopic study". The Journal of Comparative Neurology. 168 (1): 75–111. doi:10.1002/cne.901680105. PMID 819471. S2CID 11962279.
  4. ^ Yelnik J, Percheron G (1979). "Subthalamic neurons in primates: a quantitative and comparative analysis". Neuroscience. 4 (11): 1717–1743. doi:10.1016/0306-4522(79)90030-7. PMID 117397. S2CID 40909863.
  5. ^ Lévesque JC, Parent A (May 2005). "GABAergic interneurons in human subthalamic nucleus". Movement Disorders. 20 (5): 574–584. doi:10.1002/mds.20374. PMID 15645534. S2CID 9551517.
  6. ^ Alkemade A, Forstmann BU (July 2014). "Do we need to revise the tripartite subdivision hypothesis of the human subthalamic nucleus (STN)?". NeuroImage. 95: 326–329. doi:10.1016/j.neuroimage.2014.03.010. PMID 24642281. S2CID 11010595.
  7. ^ Lambert C, Zrinzo L, Nagy Z, Lutti A, Hariz M, Foltynie T, et al. (March 2012). "Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging". NeuroImage. 60 (1): 83–94. doi:10.1016/j.neuroimage.2011.11.082. PMC 3315017. PMID 22173294.
  8. ^ Canteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA (April 1990). "Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat". Brain Research. 513 (1): 43–59. doi:10.1016/0006-8993(90)91087-W. PMID 2350684. S2CID 22996045.
  9. ^ Alho EJ, Alho AT, Horn A, Martin MD, Edlow BL, Fischl B, et al. (January 2020). "The Ansa Subthalamica: A Neglected Fiber Tract". Movement Disorders. 35 (1): 75–80. doi:10.1002/mds.27901. PMID 31758733.
  10. ^ Cragg SJ, Baufreton J, Xue Y, Bolam JP, Bevan MD (October 2004). "Synaptic release of dopamine in the subthalamic nucleus". The European Journal of Neuroscience. 20 (7): 1788–1802. doi:10.1111/j.1460-9568.2004.03629.x. PMID 15380000. S2CID 14698708.
  11. ^ a b Nauta HJ, Cole M (July 1978). "Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat". The Journal of Comparative Neurology. 180 (1): 1–16. doi:10.1002/cne.901800102. PMID 418083. S2CID 43046462.
  12. ^ a b Smith Y, Hazrati LN, Parent A (April 1990). "Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method". The Journal of Comparative Neurology. 294 (2): 306–323. doi:10.1002/cne.902940213. PMID 2332533. S2CID 9667393.
  13. ^ Kita H, Chang HT, Kitai ST (April 1983). "The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis". The Journal of Comparative Neurology. 215 (3): 245–257. doi:10.1002/cne.902150302. PMID 6304154. S2CID 32152785.
  14. ^ Surmeier DJ, Mercer JN, Chan CS (June 2005). "Autonomous pacemakers in the basal ganglia: who needs excitatory synapses anyway?". Current Opinion in Neurobiology. 15 (3): 312–318. doi:10.1016/j.conb.2005.05.007. PMID 15916893. S2CID 42900941.
  15. ^ Levy R, Hutchison WD, Lozano AM, Dostrovsky JO (October 2000). "High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor". The Journal of Neuroscience. 20 (20): 7766–7775. doi:10.1523/JNEUROSCI.20-20-07766.2000. PMC 6772896. PMID 11027240.
  16. ^ Lintas A, Silkis IG, Albéri L, Villa AE (January 2012). "Dopamine deficiency increases synchronized activity in the rat subthalamic nucleus" (PDF). Brain Research. 1434 (3): 142–151. doi:10.1016/j.brainres.2011.09.005. PMID 21959175. S2CID 14636489.
  17. ^ Plenz D, Kital ST (August 1999). "A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus". Nature. 400 (6745): 677–682. Bibcode:1999Natur.400..677P. doi:10.1038/23281. PMID 10458164. S2CID 4356230.
  18. ^ Yelnik J (2002). "Functional anatomy of the basal ganglia". Movement Disorders. 17 (Suppl. 3): S15–S21. doi:10.1002/mds.10138. PMID 11948751. S2CID 40925638.
  19. ^ Sato F, Lavallée P, Lévesque M, Parent A (January 2000). "Single-axon tracing study of neurons of the external segment of the globus pallidus in primate". The Journal of Comparative Neurology. 417 (1): 17–31. doi:10.1002/(SICI)1096-9861(20000131)417:1<17::AID-CNE2>3.0.CO;2-I. PMID 10660885. S2CID 84665164.
  20. ^ Smith Y, Wichmann T, DeLong MR (May 1994). "Synaptic innervation of neurones in the internal pallidal segment by the subthalamic nucleus and the external pallidum in monkeys". The Journal of Comparative Neurology. 343 (2): 297–318. doi:10.1002/cne.903430209. PMID 8027445. S2CID 24968074.
  21. ^ Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ (October 2002). "Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network". Trends in Neurosciences. 25 (10): 525–531. doi:10.1016/S0166-2236(02)02235-X. PMID 12220881. S2CID 8127062.
  22. ^ Bergman H, Wichmann T, DeLong MR (September 1990). "Reversal of experimental parkinsonism by lesions of the subthalamic nucleus". Science. 249 (4975): 1436–1438. Bibcode:1990Sci...249.1436B. doi:10.1126/science.2402638. PMID 2402638.
  23. ^ Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B (April 1993). "Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys". The European Journal of Neuroscience. 5 (4): 382–389. doi:10.1111/j.1460-9568.1993.tb00505.x. PMID 8261116.
  24. ^ Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A, et al. (1993). "[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]". Revue Neurologique. 149 (3): 175–176. PMID 8235208.
  25. ^ Bekar L, Libionka W, Tian GF, Xu Q, Torres A, Wang X, et al. (January 2008). "Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor". Nature Medicine. 14 (1): 75–80. doi:10.1038/nm1693. PMID 18157140. S2CID 7107064.
  26. ^ Martínez-Fernández R, Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Shah BB, Hernández-Fernández F, et al. (December 2020). "Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease". The New England Journal of Medicine. 383 (26): 2501–2513. doi:10.1056/NEJMoa2016311. PMID 33369354.
  27. ^ Laganiere S, Boes AD, Fox MD (June 2016). "Network localization of hemichorea-hemiballismus". Neurology. 86 (23): 2187–2195. doi:10.1212/WNL.0000000000002741. PMC 4898318. PMID 27170566.
  28. ^ Carter R. The Human Brain Book. pp. 58, 233.
  29. ^ Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, et al. (November 2008). "Subthalamic nucleus stimulation in severe obsessive-compulsive disorder". The New England Journal of Medicine. 359 (20): 2121–2134. doi:10.1056/NEJMoa0708514. PMID 19005196.
  30. ^ Bergman H, Wichmann T, DeLong MR (September 1990). "Reversal of experimental parkinsonism by lesions of the subthalamic nucleus". Science. 249 (4975): 1436–1438. Bibcode:1990Sci...249.1436B. doi:10.1126/science.2402638. PMID 2402638.
  31. ^ Lofredi R, Auernig GC, Irmen F, Nieweler J, Neumann WJ, Horn A, et al. (February 2021). "Subthalamic stimulation impairs stopping of ongoing movements". Brain. 144 (1): 44–52. doi:10.1093/brain/awaa341. PMID 33253351.
  32. ^ Frank MJ, Samanta J, Moustafa AA, Sherman SJ (November 2007). "Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism". Science. 318 (5854): 1309–1312. Bibcode:2007Sci...318.1309F. doi:10.1126/science.1146157. PMID 17962524. S2CID 2718110.
  33. ^ Aron AR, Behrens TE, Smith S, Frank MJ, Poldrack RA (April 2007). "Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI". The Journal of Neuroscience. 27 (14): 3743–3752. doi:10.1523/JNEUROSCI.0519-07.2007. PMC 6672420. PMID 17409238.
  34. ^ Fife KH, Gutierrez-Reed NA, Zell V, Bailly J, Lewis CM, Aron AR, et al. (July 2017). Uchida N (ed.). "Causal role for the subthalamic nucleus in interrupting behavior". eLife. 6: e27689. doi:10.7554/eLife.27689. PMC 5526663. PMID 28742497.
  35. ^ Guillaumin A, Serra GP, Georges F, Wallén-Mackenzie Å (March 2021). "Experimental investigation into the role of the subthalamic nucleus (STN) in motor control using optogenetics in mice". Brain Research. 1755: 147226. doi:10.1016/j.brainres.2020.147226. PMID 33358727.
Retrieved from "https://wiki.riteme.site/w/index.php?title=Subthalamic_nucleus&oldid=1239432263"